Pliant Therapeutics (PLRX) Payables (2019 - 2025)
Pliant Therapeutics (PLRX) has disclosed Payables for 7 consecutive years, with $480000.0 as the latest value for Q4 2025.
- On a quarterly basis, Payables fell 91.95% to $480000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $480000.0, a 91.95% decrease, with the full-year FY2025 number at $480000.0, down 91.95% from a year prior.
- Payables was $480000.0 for Q4 2025 at Pliant Therapeutics, down from $485000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $7.3 million in Q1 2024 to a low of $480000.0 in Q4 2025.
- A 5-year average of $3.3 million and a median of $3.0 million in 2021 define the central range for Payables.
- Peak YoY movement for Payables: skyrocketed 416.35% in 2024, then crashed 92.96% in 2025.
- Pliant Therapeutics' Payables stood at $3.0 million in 2021, then tumbled by 46.82% to $1.6 million in 2022, then soared by 186.77% to $4.5 million in 2023, then surged by 31.54% to $6.0 million in 2024, then tumbled by 91.95% to $480000.0 in 2025.
- Per Business Quant, the three most recent readings for PLRX's Payables are $480000.0 (Q4 2025), $485000.0 (Q3 2025), and $1.4 million (Q2 2025).